Drug Shortage Report for STAXYN
| Report ID | 62147 |
| Drug Identification Number | 02372436 |
| Brand name | STAXYN |
| Common or Proper name | Vardenafil Tablets |
| Company Name | BAYER INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | VARDENAFIL |
| Strength(s) | 10MG |
| Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
| Route of administration | ORAL |
| Packaging size | 4's |
| ATC code | G04BE |
| ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2018-11-15 |
| Actual start date | 2018-11-13 |
| Estimated end date | Unknown |
| Actual end date | 2022-08-31 |
| Shortage status | Resolved |
| Updated date | 2022-09-29 |
| Company comments | Dormant DIN |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2920 MATHESON BLVD EAST MISSISSAUGA, ONTARIO CANADA L4W 5R6 |
| Company contact information | 1-800-265-7382 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.